2024-11-01 2026-02-28 false No description of principal activity Capium Accounts Production 1.1 13681644 2024-11-01 2026-02-28 13681644 bus:FullAccounts 2024-11-01 2026-02-28 13681644 bus:Micro-entities 2024-11-01 2026-02-28 13681644 bus:AuditExemptWithAccountantsReport 2024-11-01 2026-02-28 13681644 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2026-02-28 13681644 bus:PrivateLimitedCompanyLtd 2024-11-01 2026-02-28 13681644 2024-11-01 2026-02-28 13681644 2026-02-28 13681644 bus:RegisteredOffice 2024-11-01 2026-02-28 13681644 core:WithinOneYear 2026-02-28 13681644 core:AfterOneYear 2026-02-28 13681644 1 2024-11-01 2026-02-28 13681644 bus:Director1 2024-11-01 2026-02-28 13681644 bus:Director1 2026-02-28 13681644 bus:Director1 2023-11-01 2024-10-31 13681644 bus:Director2 2024-11-01 2026-02-28 13681644 bus:Director2 2026-02-28 13681644 bus:Director2 2023-11-01 2024-10-31 13681644 bus:Director3 2024-11-01 2026-02-28 13681644 bus:Director3 2026-02-28 13681644 bus:Director3 2023-11-01 2024-10-31 13681644 bus:Director4 2024-11-01 2026-02-28 13681644 bus:Director4 2026-02-28 13681644 bus:Director4 2023-11-01 2024-10-31 13681644 bus:Director5 2024-11-01 2026-02-28 13681644 bus:Director5 2026-02-28 13681644 bus:Director5 2023-11-01 2024-10-31 13681644 2023-11-01 13681644 bus:LeadAgentIfApplicable 2024-11-01 2026-02-28 13681644 2023-11-01 2024-10-31 13681644 2024-10-31 13681644 core:WithinOneYear 2024-10-31 13681644 core:AfterOneYear 2024-10-31 13681644 bus:EntityAccountantsOrAuditors 2023-11-01 2024-10-31 13681644 core:CostValuation core:Non-currentFinancialInstruments 2026-02-28 13681644 core:CostValuation core:Non-currentFinancialInstruments 2024-10-31 13681644 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-02-28 13681644 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-02-28 13681644 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-02-28 13681644 core:Non-currentFinancialInstruments 2026-02-28 13681644 core:Non-currentFinancialInstruments 2024-10-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 13681644
England and Wales
UPACARE HEALTH LTD
Unaudited Financial Statements
Period of accounts Start date: 01 November 2024 End date: 28 February 2026

UpaCare Health Ltd Statement of Financial Position As at 28 February 2026
|  | 2026 |  | 2024
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Current assets |  | 1,092 |  |  | 403,479 |
Creditors: amount falling due within one year |  | (46,910) |  |  | (342,092) |
Net current assets |  |  | (45,818) |  |  | 61,387
Total assets less current liabilities |  |  | (45,818) |  |  | 61,387
Net assets |  |  | (45,818) |  |  | 61,387
Capital and reserves |  |  | (45,818) |  |  | 61,387
NOTES TO THE ACCOUNTS General Information UpaCare Health Ltd is a private company, limited by shares, registered in England and Wales, registration number 13681644, registration address 17 Main Street, Ponteland, Tyne & Wear, NE20 9NH. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention. The financial statements are prepared in sterling which is the functional currency of the company. Going concern basis The Company ceased trading on 28th February 2026.
2. | Average number of employees Average number of employees during the period was 5 (2024 : 5).
For the period ended 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' Responsibilities: The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the board of directors on 01 May 2026 and were signed on its behalf by:
-------------------------------- Sumitra Kafle-Nath Director
1